✦ LIBER ✦

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer

✍ Scribed by Ahn, Myung-Ju; Yang, James Chih-Hsin; Liang, Jun; Kang, Jin-Hyoung; Xiu, Qingyu; Chen, Yuh-Min; Blair, Julie Michelle; Peng, Guangbin; Linn, Carlos; Orlando, Mauro

Book ID: 119320786
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 550 KB
Volume: 77
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of sequential gemcitabine

Phase II trial of sequential gemcitabine followed by cisplatin in patients with advanced non small cell lung cancer

✍ Foo, K.F; Leong, S.S; Ang, P; See, H.T; Ong, S; Wee, J; Fong, K.W; Machin, D; Ta 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB

An indirect comparison of bevacizumab pl

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Induction Pemetrexed and Cisplatin Follo

Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life–Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer (ERACLE)

✍ Domenico Galetta; Salvatore Pisconti; Saverio Cinieri; Giovanni Luigi Pappagallo 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 235 KB

O-271 Phase II randomized study of pemet

O-271 Phase II randomized study of pemetrexed plus carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

✍ Scagliotti, G.V.; Kortsik, C.; Manegold, C.; Dark, G.; Crino, L.; O'Brien, M.E.R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

P-488 Phase II randomized trial of singl

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

✍ Gridelli, C.; Reck, M.; Gregorc, V.; Migliorino, M.; Muller, T.; Manegold, C.; F 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB